Fatty liver disease and bone density in adults
Part of Bones, joints & muscles, Digestive system, Hormones & metabolism clinical trials.
This study looks at how fatty liver disease affects bone density in adults with obesity. If you have fatty liver and are overweight, this research might help understand your bone health better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older (and premenopausal if you're a woman)
- You have been diagnosed with fatty liver disease (NAFLD) – for example, by ultrasound or FibroScan
- You have obesity (high body mass index) or related issues like diabetes or high cholesterol
- You are not a heavy drinker
- You do not have other liver diseases (like hepatitis) or conditions that affect bone health (like thyroid or kidney disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.
This study looks at blood cells and factors in people with metabolic diseases like fatty liver, prediabetes, or type 2 diabetes. It aims to better understand these conditions by comparing them with healthy volunteers.
This trial looks at how common fatty liver disease is in people with type 1 diabetes. Doctors will check your liver with tests to learn more and find out if you might be at risk.
This study follows people with nonalcoholic fatty liver disease to better understand the condition. It uses an MRI scan and collects body samples to help researchers study changes over time.
This study tracks how liver scarring (fibrosis) and fat buildup (steatosis) change over time in people with nonalcoholic fatty liver disease (NAFLD). It helps doctors understand risk factors so they can better predict and manage the disease.
Hear when a new NAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.